Jim Simons acquired 297k Larimar Therapeutics shares worth $821k. That's 0.00% of their equity portfolio (2245th largest holding). The first Larimar Therapeutics trade was made in Q2 2020. Since then Jim Simons bought shares twelve more times and sold shares on twelve occasions. The investor's estimated purchase price is $1.48M, resulting in a loss of 44%.